Novanta (NOVT) CEO insider sale under pre-set 10b5-1 share plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Novanta Inc. Chief Executive Officer and director Matthijs Glastra reported an insider sale of common stock. On January 9, 2026, a total of 6,177 shares of Novanta common stock were sold at $130 per share, coded as an open market sale.
The filing notes that these sales were carried out under a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee. After this transaction, Glastra beneficially owned 78,867 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust, indicating he continues to hold a significant equity position in Novanta.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 6,177 shares ($803,010)
Net Sell
2 txns
Insider
Glastra Matthijs
Role
Chief Executive Officer
Sold
6,177 shs ($803K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,177 | $130.00 | $803K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 78,867 shares (Direct);
Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Novanta (NOVT) report in this Form 4?
The Form 4 reports that Matthijs Glastra, Novanta Inc.’s Chief Executive Officer and director, was involved in the sale of 6,177 shares of Novanta common stock at $130 per share on January 9, 2026.
What type of security was involved in the Novanta CEO’s Form 4 filing?
The transaction involved Novanta Inc. common stock. No derivative securities were reported in Table II of this Form 4.
Does this Novanta Form 4 indicate any derivative security transactions?
No. Table II for derivative securities in the Form 4 is blank, indicating no derivative securities were acquired or disposed of in the reported period.